MSKCC medical oncologists share expertise in HSCT, Spanish background, a gift for mentoring, and 100 peer-reviewed publications written together...
A German family’s tragedy launched DKMS, a multinational organization whose goal is to “delete blood cancer.”
This case shows the potential of BCMA-targeted CAR T-cells to cross the blood-brain barrier in a subset of patients and cause a progressive...
Rare Diseases Report 2021
A drug approved in 2020 for treatment of advanced multiple myeloma has been shown to benefit patients newly diagnosed with the disease.
“The approval will help clinicians address unmet patient needs by reducing the administration time from hours to just minutes and reducing the...
From the Journals
New study sheds light on how vulnerable multiple myeloma patients are to COVID-19.
The FDA also hinted at “a future public meeting to discuss the safety findings and explore the continued marketing of Pepaxto,” which has a price...
The vaccine consists of patient-specific synthetic neoantigen peptides and is given to patients in the adjuvant setting.